Data Collective Iv Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Data Collective Iv Gp, LLC
- $83.3 Million
- Q2 2024
A detailed history of Data Collective Iv Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 5,941,120 shares of RXRX stock, worth $39.4 Million. This represents 53.46% of its overall portfolio holdings.
Number of Shares
5,941,120
Previous 5,941,120
-0.0%
Holding current value
$39.4 Million
Previous $59.2 Million
24.77%
% of portfolio
53.46%
Previous 51.78%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
291Shares Held
241MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$218 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$168 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$115 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$102 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.2B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...